
Experienced Research Instructor at SUNY Downstate Medical Center in New York, US, specializing in pulmonary medicine with a robust focus on chronic obstructive pulmonary disease (COPD) research.
Extensive background includes leading various projects igniting significant findings on the role of molecular mechanisms, including mRNA binding proteins and phosphatases in airway inflammation.
Strong skillset in designing and conducting in vitro and in vivo experiments, employing techniques such as PCR, Western blotting, and RNA sequencing while managing laboratory operations and editing scientific manuscripts.
Passionate about advancing renewable energy adoption and creating lasting impacts in the industry.
- Investigation of the role of HuR, mRNA binding protein (ELAVL1) in COPD Airway Epithelial Cells
- Examination of the role of key phosphatases in the regulation of airway inflammation, specifically protein phosphatase 2A and 2B and its subunits.
- Examination of the potential of multiple antioxidants to modify phosphatase activity and identify candidates for future therapeutic treatment of COPD.
Investigate phosphatase and kinases signalling in cigarette smoke induced lung damage and The role of respiratory syncytial virus infections in COPD exacerbations.
Project focused on the molecular mechanisms involved in smoke-induced regulation of matrix metalloproteinases in vascular cells.
*US Patent Provisional Application No.: 61/ 504,697, TLR4 PATHWAY BLOCKADE TO TREAT LUNG DISEASE, issued July 5, 2011.
Drug discovery and development company focused on the creation of therapeutic monoclonal antibodies for the treatment of inflammatory diseases and immune-related disorders.
Conducted research to find pollutants or hazards in the sea coast environment.